跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
REXULTI brexpiprazole 2 mg film coated tablet blister pack - TGA Drug Approval Details
Approvals
/
TGA
/
REXULTI brexpiprazole 2 mg film coated tablet blister pack
Approved
STANDARD
REXULTI brexpiprazole 2 mg film coated tablet blister pack
Lundbeck Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
9062259dcec1f7fc
Company
Lundbeck Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
9062259dcec1f7fc
Product Name
REXULTI brexpiprazole 2 mg film coated tablet blister pack
Artg Id
273223
Artg Name
REXULTI brexpiprazole 2 mg film coated tablet blister pack
Sponsor
Lundbeck Australia Pty Ltd
Company Detail Path
/organization/lundbeck-australia-pty-ltd
Artg Date
2017-05-19
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/de90ab93aac67fb9578282279bcd5ada.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/412fa0b09219d47cf413e279f97ad8ed.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
9062259dcec1f7fc
Type
Standard
Back to TGA Approvals